Key Highlights
- Magnera Corporation (NYSE:MAGN) rose 15.03% in after-hours trading on November 18, 2026, an increase of around 15%, after the fourth-quarter results were published.
- Quarterly adjusted EBITDA climbed 8% to USD 97 million from USD 851 million in net sales, while Operating Cash Flow hit a high of USD 99 million.
- For fiscal 2027, the company sees adjusted EBITDA landing between USD 390 million and USD 410 million, with free cash flow in a USD 110 million to USD 130 million range.
- A USD 106 million Impairment pushed the quarter to a net loss of USD 141 million, yet attention centred on cash generation and Debt paydown.
Profit Improves Despite Softer Demand
Magnera came together when a nonwovens Business split off from a large packaging company merged with a specialty materials maker, and it produces engineered fabrics for hygiene goods, wipes, healthcare and industrial markets. Its fiscal fourth quarter ended September 26, and the figures show cost controls now boosting Earnings even though Demand is still weak. Sales increased by 1% to USD 851 million from USD 839 million. Organic Volume declined 4%, with a 2% fall in the Americas and 6% in the rest of the world, but better selling prices supplied an extra USD 43 million, largely by moving higher raw material costs onto customers. Adjusted EBITDA went up 8% to USD 97 million from USD 90 million, with USD 65 million from the Americas and USD 32 million from the rest of the world. The company attributed most of the gain to a USD 9 million favourable price-cost spread, aided by an internal efficiency programme and Merger synergies.
Impairments, Cash Flow and Debt Repayment
The reported picture was less flattering. Operating Income swung to a loss of USD 90 million from USD 10 million of income the year before, because USD 106 million of Goodwill and other impairments were booked, of which USD 65 million related to the Americas and USD 41 million elsewhere. The net loss grew to USD 141 million, up from USD 40 million. Impairments involve no cash, however, and cash generation was excellent: operating cash flow set a quarterly record of USD 99 million, and USD 57 million of debt was retired. For the full fiscal 2026, sales rose 3% to USD 3.30 billion and adjusted EBITDA 7% to USD 378 million; operating cash flow came in at USD 178 million and free cash flow at USD 115 million. Borrowings dropped from USD 1.95 billion to near USD 1.85 billion, and the company held USD 294 million of cash. Leverage is still elevated against earnings, so trimming debt stays the top near-term objective, although the trajectory is improving.
Fiscal 2027 Outlook and Valuation Context
Fiscal 2027 guidance seems to be the main driver of the after-hours rally. On a constant currency basis, management sees adjusted EBITDA landing somewhere in the USD 390 million to USD 410 million zone, with the midpoint roughly 6% higher than fiscal 2026, plus operating cash generation between USD 195 million and USD 215 million, capex close to USD 85 million and free cash flow between USD 110 million and USD 130 million. The stakes are high because the Equity was worth only about USD 490 million before the move, so projected free cash flow equates to an unusually large return on equity. Management has referred to a free-cash-flow Yield above 25%, calculated on its September market value. Risks remain, including soft hygiene and wipes demand, volatile raw material costs, foreign currency exposure and more restructuring charges. A November 19 conference call should shed light on volumes and pricing.
Where Things Stand
Magnera climbed about 15% after hours on November 18, as quarterly adjusted EBITDA increased 8%, cash flow reached a record and the fiscal 2027 range of USD 390 million to USD 410 million for EBITDA outweighed a sizeable impairment. The gain has yet to be confirmed in regular trading, and high leverage keeps debt reduction at the heart of the story.





_11_19_2026_10_01_30_706375.jpg)
Please wait processing your request...